Background Optimal drug treatment for patients with resistant hypertension is undefined. We
aimed to test the hypotheses that resistant hypertension is most often caused by excessive …

Background The treatment of resistant hypertension (RH) is challenging. Several
observational studies have suggested that the addition of spironolactone to triple-drug …

Objective: Resistant hypertension (res-HTN) is a challenging problem, but little is known of
res-HTN in patients with coronary artery disease (CAD). In this post-hoc INternational …

Abstract Treatment-resistant hypertension (TRH) is an increasingly common and clinically
challenging hypertension phenotype associated with adverse impact on cardiovascular …

Little is known of US trends in antihypertensive drug use for patients with treatment-resistant
hypertension (TRH). We analyzed antihypertensive use among patients with TRH (treated …

Team-based care has been recommended for patients with treatment-resistant hypertension
(TRH), but its efficacy in this setting is unknown. We compared a physician-pharmacist …

Background: Adrenomedullin (ADM), adrenomedullin 2 (ADM2), and CGRP family peptides
are important regulators of vascular vasotone and integrity, neurotransmission, and …

Little is known about the impact of treatment-resistant hypertension (TRH) on health-related
quality of life (HrQoL). We aimed to compare HrQoL measures in adults with apparent TRH …

Aim To quantify the relation between apparent treatment resistant hypertension (aTRH) and
the risk of recurrent major adverse cardiovascular events (MACE including stroke …

Диагностика и лечение артериальной гипертензии при хронической болезни почек КОРЗИНА
ПОИСК НАВИГАТОР СЕССИЯ КОНТАКТЫ ИНФОРМАЦИЯ О ПУБЛИКАЦИИ eLIBRARY ID …